A functional polymorphism in the SCN1A gene is not associated with carbamazepine dosages in Austrian patients with epilepsy

Epilepsia. 2008 Jun;49(6):1108-9. doi: 10.1111/j.1528-1167.2008.01549_4.x.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anticonvulsants / administration & dosage*
  • Austria
  • Carbamazepine / administration & dosage*
  • Dose-Response Relationship, Drug
  • Drug Resistance
  • Epilepsy / drug therapy*
  • Epilepsy / genetics*
  • Genotype*
  • Humans
  • NAV1.1 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins / genetics*
  • Polymorphism, Single Nucleotide / genetics*
  • Reproducibility of Results
  • Sodium Channels / genetics*

Substances

  • Anticonvulsants
  • NAV1.1 Voltage-Gated Sodium Channel
  • Nerve Tissue Proteins
  • SCN1A protein, human
  • Sodium Channels
  • Carbamazepine